$247 Million is the total value of KNOTT DAVID M's 152 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 22.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorporated | $36,819,000 | +4.8% | 353,041 | 0.0% | 14.92% | +1.1% | |
| FTAI | Fortress Trans & Infrastructure Inv. LLC | $17,361,000 | +29.0% | 888,509 | 0.0% | 7.04% | +24.4% | |
| SRCL | Sell | Stericycle, Inc. | $17,170,000 | +7.3% | 269,083 | -14.3% | 6.96% | +3.6% |
| UPLD | Upland Software, Inc. | $15,641,000 | +2.4% | 438,000 | 0.0% | 6.34% | -1.2% | |
| APO | Sell | Apollo Global Management, Inc. | $11,331,000 | -7.2% | 237,500 | -26.4% | 4.59% | -10.4% |
| GOOG | Alphabet Inc-Cl C | $10,562,000 | +9.7% | 7,900 | 0.0% | 4.28% | +5.8% | |
| FSK | FS KKR Capital Corp. | $9,361,000 | +5.2% | 1,527,000 | 0.0% | 3.80% | +1.5% | |
| MPLX | MPLX LP | $9,333,000 | -9.1% | 366,558 | 0.0% | 3.78% | -12.3% | |
| IGT | International Gaming Technologies | $9,094,000 | +5.3% | 607,500 | 0.0% | 3.69% | +1.6% | |
| MIC | Macquarie Infrastructure Corporation | $7,536,000 | +8.6% | 175,900 | 0.0% | 3.06% | +4.8% | |
| CLMT | Calumet Specialty Products Partners, LP | $7,373,000 | +0.3% | 2,020,000 | 0.0% | 2.99% | -3.2% | |
| LKQ | Sell | LKQ Corporation | $7,140,000 | -24.3% | 200,000 | -33.3% | 2.89% | -27.0% |
| TSG | Sell | The Stars Group Inc. | $6,523,000 | -20.2% | 250,000 | -54.2% | 2.64% | -23.0% |
| PFE | Pfizer Inc. | $5,168,000 | +9.1% | 131,900 | 0.0% | 2.10% | +5.2% | |
| CCXI | Buy | ChemoCentryx, Inc. | $4,195,000 | +12238.2% | 106,075 | +2021.5% | 1.70% | +12042.9% |
| AOBC | American Outdoor Brands Corporation | $3,619,000 | +58.6% | 390,000 | 0.0% | 1.47% | +53.0% | |
| EIGR | Eiger BioPharmaceuticals, Inc. | $3,493,000 | +45.4% | 234,448 | 0.0% | 1.42% | +40.2% | |
| JPM | JP Morgan Chase | $3,223,000 | +18.8% | 23,050 | 0.0% | 1.31% | +14.6% | |
| BDSI | Sell | BioDelivery Sciences International, Inc. | $3,189,000 | +46.4% | 504,607 | -2.5% | 1.29% | +41.3% |
| ABBV | AbbVie Inc. | $2,918,000 | +16.9% | 32,953 | 0.0% | 1.18% | +12.8% | |
| BMY | Buy | Bristol-Myers Squibb Company | $2,806,000 | +85.2% | 43,715 | +46.4% | 1.14% | +78.8% |
| FNMAH | Buy | Fannie Mae Float Series P | $2,670,000 | +345.7% | 254,559 | +412.0% | 1.08% | +329.4% |
| XENE | Buy | Xenon Pharmaceuticals Inc. | $2,565,000 | +52.0% | 195,657 | +4.5% | 1.04% | +46.7% |
| HZNP | Sell | Horizon Therapeutics Public Ltd. Company | $2,203,000 | +25.7% | 60,856 | -5.5% | 0.89% | +21.3% |
| AIMT | Aimmune Therapeutics, Inc. | $1,874,000 | +59.8% | 55,990 | 0.0% | 0.76% | +54.2% | |
| BLU | BELLUS Health Inc. | $1,833,000 | +17.6% | 242,611 | 0.0% | 0.74% | +13.4% | |
| VKTX | Viking Therapeutics, Inc. | $1,749,000 | +16.5% | 218,102 | 0.0% | 0.71% | +12.4% | |
| FNMAT | Sell | Fannie Mae 8.25 percent Series T | $1,663,000 | -45.3% | 146,736 | -37.4% | 0.67% | -47.3% |
| FMCKJ | Freddie Mac 8.375 percent Series Z | $1,653,000 | -9.5% | 139,500 | 0.0% | 0.67% | -12.6% | |
| STML | Buy | Stemline Therapeutics, Inc. | $1,546,000 | +37.5% | 145,475 | +34.8% | 0.63% | +32.8% |
| AB | AllianceBernstein Holdings PL Unit Ltd | $1,528,000 | +3.1% | 50,500 | 0.0% | 0.62% | -0.6% | |
| FNMAP | New | Fannie Mae Float Series F | $1,507,000 | – | 81,890 | +100.0% | 0.61% | – |
| CHRS | Buy | Coherus Biosciences, Inc. | $1,363,000 | +6.2% | 75,714 | +19.4% | 0.55% | +2.4% |
| RDUS | Sell | Radius Health Inc. | $1,323,000 | -29.9% | 65,617 | -10.4% | 0.54% | -32.4% |
| FOMX | Buy | Foamix Pharmaceuticals Ltd. | $1,269,000 | +12.5% | 381,146 | +2.7% | 0.51% | +8.4% |
| KDMN | Buy | Kadmon Holdings, Inc. | $1,246,000 | +372.0% | 275,000 | +162.7% | 0.50% | +355.0% |
| VZ | Verizon Communications Inc. | $1,124,000 | +1.6% | 18,311 | 0.0% | 0.46% | -1.9% | |
| RHP | Ryman Hospitality Ppty Inc. | $1,075,000 | +5.9% | 12,400 | 0.0% | 0.44% | +2.3% | |
| JNJ | Johnson & Johnson | $1,062,000 | +12.7% | 7,280 | 0.0% | 0.43% | +8.6% | |
| CNQ | Canadian Natural Resources Inc. | $1,037,000 | +21.6% | 32,035 | 0.0% | 0.42% | +17.3% | |
| GMREPRA | Global Medical REIT, Inc. Ser A Cum Pfd. | $943,000 | +1.4% | 35,000 | 0.0% | 0.38% | -2.3% | |
| ALKS | New | Alkermes PLC | $879,000 | – | 43,073 | +100.0% | 0.36% | – |
| MDLZ | Mondelez Int'lt Inc. | $876,000 | -0.3% | 15,900 | 0.0% | 0.36% | -3.8% | |
| T | AT&T Inc. | $862,000 | +3.2% | 22,050 | 0.0% | 0.35% | -0.6% | |
| FNMAL | Fannie Mae 4.75 percent Series M | $851,000 | -13.0% | 43,000 | 0.0% | 0.34% | -16.1% | |
| CDTX | Buy | Cidara Therapeutics, Inc. | $838,000 | +114.9% | 218,220 | +11.5% | 0.34% | +107.3% |
| KMB | Kimberly Clark Corporation | $825,000 | -3.2% | 6,000 | 0.0% | 0.33% | -6.7% | |
| DD | Dupont De Nemours Inc. | $805,000 | -10.1% | 12,545 | 0.0% | 0.33% | -13.3% | |
| FMCKM | Buy | Freddie Mac 5.57 percent Series V | $794,000 | +78.4% | 80,000 | +101.3% | 0.32% | +72.2% |
| KO | Coca Cola | $742,000 | +1.6% | 13,400 | 0.0% | 0.30% | -2.0% | |
| DOW | Dow Inc. | $687,000 | +14.9% | 12,545 | 0.0% | 0.28% | +10.8% | |
| QTNT | Quotient Limited | $671,000 | +22.4% | 70,542 | 0.0% | 0.27% | +18.3% | |
| ARNA | Arena Pharmaceuticals, Inc. | $654,000 | -0.8% | 14,391 | 0.0% | 0.26% | -4.3% | |
| FMCKL | Freddie Mac 6.02 percent Series X | $610,000 | -6.3% | 53,811 | 0.0% | 0.25% | -9.5% | |
| IBM | International Business Machines | $574,000 | -7.9% | 4,284 | 0.0% | 0.23% | -11.1% | |
| FREJP | Sell | Freddie Mac 5.3 percent | $534,000 | -75.0% | 30,000 | -70.0% | 0.22% | -75.9% |
| WPC | WP Carey | $480,000 | -10.6% | 6,000 | 0.0% | 0.20% | -13.7% | |
| CHEKW | Check Cap Ltd. @7.50 Exp. 2/28/20 | $482,000 | 0.0% | 64,309 | 0.0% | 0.20% | -3.5% | |
| FNMAS | Sell | Fannie Mae 8.25 percent Series S | $418,000 | -47.8% | 35,000 | -41.7% | 0.17% | -49.9% |
| CLBK | Columbia Financial, Inc. | $396,000 | +7.3% | 23,363 | 0.0% | 0.16% | +3.9% | |
| FMCKK | Freddie Mac 5 percent Series F | $394,000 | -16.7% | 21,590 | 0.0% | 0.16% | -19.6% | |
| FNMAO | New | Fannie Mae Float - Series G | $393,000 | – | 22,477 | +100.0% | 0.16% | – |
| KRYS | Buy | Krystal Biotech, Inc. | $392,000 | +95.0% | 7,079 | +22.1% | 0.16% | +89.3% |
| CTVA | Corteva Inc. | $371,000 | +5.7% | 12,545 | 0.0% | 0.15% | +2.0% | |
| QURE | New | uniQure N.V. | $351,000 | – | 4,900 | +100.0% | 0.14% | – |
| New | Alimera Sciences, Inc. | $342,000 | – | 45,155 | +100.0% | 0.14% | – | |
| CAG | Conagra Brands | $342,000 | +11.4% | 10,000 | 0.0% | 0.14% | +7.8% | |
| DELL | Dell Technologies Inc. | $330,000 | -0.9% | 6,426 | 0.0% | 0.13% | -4.3% | |
| FNMFM | Buy | Fannie Mae 5.1 percent Series E | $319,000 | +2800.0% | 17,500 | +3400.0% | 0.13% | +2480.0% |
| ENFC | Entegra Financial Corporation | $309,000 | +0.3% | 10,250 | 0.0% | 0.12% | -3.1% | |
| AAPL | Apple Inc. | $308,000 | +30.5% | 1,050 | 0.0% | 0.12% | +26.3% | |
| XLRN | Sell | Acceleron Pharma, Inc. | $294,000 | -65.8% | 5,547 | -74.5% | 0.12% | -67.0% |
| COLL | New | Collegium Pharmaceutical, Inc. | $257,000 | – | 12,500 | +100.0% | 0.10% | – |
| FSBW | FS Bancorp Inc. | $228,000 | +21.3% | 3,577 | 0.0% | 0.09% | +16.5% | |
| MSFT | Microsoft Corporation | $221,000 | +13.3% | 1,400 | 0.0% | 0.09% | +9.8% | |
| CPRX | Sell | Catalyst Pharmaceuticals, Inc. | $219,000 | -72.8% | 58,317 | -61.5% | 0.09% | -73.7% |
| WHLRD | Wheeler Real Estate Investment Trust, Inc. | $214,000 | +5.4% | 14,309 | 0.0% | 0.09% | +2.4% | |
| SBBP | New | Strongbridge Biopharma PLC | $209,000 | – | 100,000 | +100.0% | 0.08% | – |
| FNMAM | Fannie Mae 5.81 percent Series H | $198,000 | -13.2% | 10,000 | 0.0% | 0.08% | -16.7% | |
| CSFL | Centerstate Banks Corp | $173,000 | +3.6% | 6,942 | 0.0% | 0.07% | 0.0% | |
| FNMAN | Fannie Mae 5.125 percent Series L | $173,000 | -10.4% | 8,680 | 0.0% | 0.07% | -13.6% | |
| GMED | Globus Medical, Inc. | $171,000 | +15.5% | 2,900 | 0.0% | 0.07% | +11.3% | |
| VRCA | Verrica Pharmaceuticals, Inc. | $162,000 | +7.3% | 10,207 | 0.0% | 0.07% | +4.8% | |
| KHC | The Kraft Heinz Company | $158,000 | +15.3% | 4,900 | 0.0% | 0.06% | +10.3% | |
| TTE | Total SA | $159,000 | +6.7% | 2,860 | 0.0% | 0.06% | +1.6% | |
| HRGG | Heritage NOLA Bancorp Inc. | $153,000 | +0.7% | 12,000 | 0.0% | 0.06% | -3.1% | |
| LEGH | Legacy Housing Corporation | $150,000 | +2.7% | 9,000 | 0.0% | 0.06% | 0.0% | |
| VLY | New | Valley National Bancorp | $143,000 | – | 12,480 | +100.0% | 0.06% | – |
| CUZ | Cousins Properties | $138,000 | +9.5% | 3,357 | 0.0% | 0.06% | +5.7% | |
| CFFN | Capitol Federal Financial Inc. | $135,000 | 0.0% | 9,800 | 0.0% | 0.06% | -3.5% | |
| OXY | Occidental Pete Corp | $122,000 | -8.3% | 2,973 | 0.0% | 0.05% | -12.5% | |
| Merck & Co. Inc. | $118,000 | +8.3% | 1,300 | 0.0% | 0.05% | +4.3% | ||
| MDT | Medtronics | $119,000 | +4.4% | 1,050 | 0.0% | 0.05% | 0.0% | |
| FNB | FNB Corporation | $113,000 | +9.7% | 8,905 | 0.0% | 0.05% | +7.0% | |
| FMCCP | Freddie Mac 6 percent Series P | $104,000 | -10.3% | 5,200 | 0.0% | 0.04% | -14.3% | |
| FMCKO | New | Freddie Mac 5.9 percent Series U | $100,000 | – | 10,000 | +100.0% | 0.04% | – |
| MEIP | MEI Pharma, Inc. | $96,000 | +47.7% | 38,590 | 0.0% | 0.04% | +44.4% | |
| ASND | New | Ascendis Pharma A/S | $91,000 | – | 656 | +100.0% | 0.04% | – |
| NVLNF | Novelion Therapeutics, Inc. | $77,000 | -2.5% | 109,135 | 0.0% | 0.03% | -6.1% | |
| GE | General Electric | $52,000 | +23.8% | 4,680 | 0.0% | 0.02% | +16.7% | |
| BMYRT | New | Bristol-Myers Squibb Company - CVR | $48,000 | – | 15,847 | +100.0% | 0.02% | – |
| LLY | Eli Lilly Inc. | $39,000 | +14.7% | 300 | 0.0% | 0.02% | +14.3% | |
| PBCT | Peoples United Financial | $25,000 | +8.7% | 1,500 | 0.0% | 0.01% | 0.0% | |
| SVC | Service Ppty Trust | $24,000 | -7.7% | 1,000 | 0.0% | 0.01% | -9.1% | |
| BNS | Bank Nova Scotia Halifax | $23,000 | 0.0% | 400 | 0.0% | 0.01% | -10.0% | |
| EXP | Eagle Materials Inc. | $21,000 | 0.0% | 228 | 0.0% | 0.01% | 0.0% | |
| CC | Chemours Co. | $21,000 | +16.7% | 1,160 | 0.0% | 0.01% | +12.5% | |
| STWD | Starwood Ppty | $10,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% | |
| CLNS | Colony Northstar Inc. | $7,000 | -22.2% | 1,466 | 0.0% | 0.00% | -25.0% | |
| SCU | Sculptor Capital Mgmt | $4,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% | |
| AMLP | Alerian MLP | $5,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% | |
| CHEK | Check Cap Ltd. | $4,000 | 0.0% | 2,224 | 0.0% | 0.00% | 0.0% | |
| Exit | Bellicum Pharmaceuticals @ 5 exp 11/19 | $0 | – | -100 | -100.0% | 0.00% | – | |
| RMR | RMR Group Inc. | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – | |
| WAB | WABTEC | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – | |
| ALC | Exit | Alcon, Inc | $0 | – | -600 | -100.0% | -0.02% | – |
| Exit | Ascendis Pharma A/S | $0 | – | -656 | -100.0% | -0.03% | – | |
| LXRX | Exit | Lexicon Pharmaceuticals, Inc. | $0 | – | -29,800 | -100.0% | -0.04% | – |
| OFIX | Exit | Orthofix Medical Inc. | $0 | – | -2,000 | -100.0% | -0.04% | – |
| NVS | Exit | Novartis AG | $0 | – | -1,500 | -100.0% | -0.06% | – |
| ORIT | Exit | Oritani Financial Corp | $0 | – | -7,800 | -100.0% | -0.06% | – |
| BLCM | Exit | Bellicum Pharmaceuticals | $0 | – | -168,203 | -100.0% | -0.07% | – |
| ALIM | Exit | Alimera Sciences, Inc. | $0 | – | -458,120 | -100.0% | -0.11% | – |
| AUPH | Exit | Aurinia Pharmaceuticals Inc. | $0 | – | -53,000 | -100.0% | -0.12% | – |
| CBAY | Exit | CymaBay Therapeutics, Inc. | $0 | – | -80,889 | -100.0% | -0.17% | – |
| MIK | Exit | The Michaels Companies, Inc. | $0 | – | -150,000 | -100.0% | -0.62% | – |
| CELG | Exit | Celgene Corporation | $0 | – | -15,847 | -100.0% | -0.66% | – |
| EPRT | Exit | Essential Properties Realty Trust, Inc. | $0 | – | -80,000 | -100.0% | -0.77% | – |
| CHCT | Exit | Community Healthcare Trust Incorporated | $0 | – | -60,000 | -100.0% | -1.12% | – |
| DAL | Exit | Delta Air Lines, Inc. | $0 | – | -57,500 | -100.0% | -1.39% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.